Publication
Anti-pneumoscystis carinni activitiy of primaquine imidazolidin-4-ones
| dc.contributor.author | Vale, Nuno | |
| dc.contributor.author | Ferraz, Ricardo | |
| dc.contributor.author | Azevedo, Joana | |
| dc.contributor.author | Araújo, Maria João | |
| dc.contributor.author | Moreira, Rui | |
| dc.contributor.author | Collins, Margaret S. | |
| dc.contributor.author | Cushion, Melanie T. | |
| dc.contributor.author | Gomes, Paula | |
| dc.date.accessioned | 2013-09-24T15:40:44Z | |
| dc.date.available | 2013-09-24T15:40:44Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | Pneumocystis pneumonia (PCP) is one of the most frequent causes of mortality among HIV-infected patients. Primaquine (PQ) is an antimalarial 8-aminoquinoline effective against PCP when given in combination with clindamycin. This has drawn the attention of Medicinal Chemists towards the anti-PCP activity of 8-aminoquinolines, not only confined to those exhibiting antimalarial activity [1]. It is thought that anti-PCP 8-aminoquinolines exert their anti-PCP activity by acting on the electronic transport and redox system of the P. carinii pathogen [1]. Recently, our research group has been developing imidazolidin-4-one derivatives of PQ (Scheme 1), targeting novel compounds with improved therapeutic action, namely, higher resistance to metabolic inactivation, lower toxicity and equal or higher antimalarial activity than that of the parent drug [2,3]. These imidazolidin-4-ones were seen to block the transmission of rodent malaria, caused by Plasmodium berghei on BalbC mice, to the mosquito vector Anopheles stephensi [3]. The anti-PCP activity of our PQ derivatives is now under study and preliminary in vitro assays [4] show that some of the compounds exhibit slight to moderate activity after a 72 h incubation period against P. carinii. In one case, the IC50 was comparable to that of parent PQ. Both these studies and forthcoming results from ongoing biological assays will be presented and discussed. | por |
| dc.identifier.uri | http://hdl.handle.net/10400.22/2008 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Instituto Politécnico do Porto. Escola Superior de Tecnologia da Saúde do Porto | por |
| dc.publisher | Faculdade de Ciências do Porto. Faculdade de Farmácia da Universidade de Lisboa | |
| dc.publisher | University of Cincinnati | |
| dc.title | Anti-pneumoscystis carinni activitiy of primaquine imidazolidin-4-ones | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.title | XIXth International Symposium of Medicinal Chemistry | por |
| person.familyName | Ferraz | |
| person.givenName | Ricardo | |
| person.identifier.ciencia-id | 001E-71CE-F92D | |
| person.identifier.orcid | 0000-0002-1761-117X | |
| person.identifier.rid | G-5639-2011 | |
| person.identifier.scopus-author-id | 24464208500 | |
| rcaap.rights | openAccess | por |
| rcaap.type | conferenceObject | por |
| relation.isAuthorOfPublication | a5a8faa7-12a5-4b1c-bced-44c895677397 | |
| relation.isAuthorOfPublication.latestForDiscovery | a5a8faa7-12a5-4b1c-bced-44c895677397 |